Inhibitors of meprin α and β

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 10975019
APP PUB NO 20190127317A1
SERIAL NO

16094460

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel hydroxamic acid derivatives as inhibitors of meprin β and/or α, pharmaceutical compositions comprising such compounds, methods for treatment or prophylaxis of diseases or conditions, especially such that are related to meprin β and/or α, and compounds and pharmaceutical compositions for use in such methods.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VIVORYON THERAPEUTICS N V06120 HALLE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Buchholz, Mirko Halle, DE 26 330
Demuth, Hans-Ulrich Halle, DE 116 1907
Ramsbeck, Daniel Halle, DE 15 42
Schilling, Stephen Halle, DE 4 0
Schlenzig, Dagmar Halle, DE 12 321
Wermann, Michael Halle, DE 8 20

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 13, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 13, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00